Passionate about Developing Therapies to Advance the Treatment of Gastrointestinal (GI) Disorders
Millions of patients in the United States are living with serious, untreated, or inadequately controlled GI conditions. It is time to change that.
Our Company
We are a GI-focused company with products in development to treat serious conditions that affect patients and for which there are limited treatment options today.
Neurogastrx, Inc. is a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases.